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Abstract
Background: Galacto-oligosaccharides (GOS) are prebiotics added to commercial milk formula of infants and mothers.
In recent years, cases of allergy related to GOS in atopic children have been reported in the South East Asian region.
Case presentations: We describe a series of pregnant (n = 4) and lactating mothers (n = 2) who developed
anaphylactic reactions after consumption of maternal milk formula containing GOS. All six subjects had pre-
existing atopy and a positive skin prick test to GOS and 5/5 of the subjects who were tested had positive
basophil activation tests to GOS. All of the mothers and their babies had normal neonatal outcomes after the
reactions.
Conclusions: The supplementation of GOS into milk and beverages in the Asian region should take into account the
rare chance of allergenicity of GOS in the atopic population.
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Background
Anaphylaxis in pregnancy is uncommon, and is often
caused by antibiotics or drugs administered during labor
[1–3]. It can result in maternal morbidity and neonatal
death [1, 4].
Galacto-oligosaccharides (GOS) are a mixture of sugar
chains up to seven units in length, which are synthesized
by β galactosidases which transfer galactose to lactose
[5]. β galactosidase enzymes from different sources (e.g.
fungal, bacterial) are known and used for GOS produc-
tion [5, 6]. The GOS produced by enzymes from differ-
ent sources result in GOS of varying composition. GOS
function as prebiotics in infants [7], with promising re-
sults in mouse studies suggesting effects on immune
markers associated with tolerance, diminished allergic
sensitization in female offspring, and reduced allergic
asthma symptoms in male offspring [8–10]. The supple-
mentation of the prebiotic mixture GOS/FOS (fructo-ol-
igosaccharides) in the last trimester of pregnancy was
investigated in a clinical trial. The prebiotic mixture was
well tolerated by the mothers and no side-effects were
observed in mothers or their offspring. Furthermore, the
prebiotics also altered the maternal gut composition to-
wards the bacteria thought to be favorable towards im-
mune tolerance, although this effect was not shown to
be transferable to the newborn infant [11].
GOS does not occur naturally in foods, although a num-
ber of GOS-structures have been found in high concentra-
tions in human colostrum [12]. It is a manufactured
prebiotic with a safe history of use and US FDA-approved
GRAS (Generally Recognized As Safe) status [13, 14].
GOS is mainly applied as ingredient in infant milk formu-
lae worldwide (Asia, Australia, America, Europe), but has
also been supplemented to food products in recent years
(e.g. yoghurt, drinks, bars, food supplements). When
present, GOS is an added ingredient to milk formulae at
up to 8 g per liter.
Unfortunately, application of GOS in milk formulae
and food products was accompanied by reports of rare
anaphylactic/allergic reactions to GOS in the Asian re-
gion: Japan, Singapore, Malaysia, Vietnam and Thailand
[15–17]. The severity of the reactions varies and affected
both adults as well as children as young as preschool
age. Some developed anaphylaxis and required
hospitalization. This is unusual as there is evidence to
suggest an IgE-mediated reaction [16], yet GOS is a
* Correspondence: jian_yi_soh@nuhs.edu.sg
1Department of Paediatrics, National University Hospital, Tower Block Level
12, 1E Kent Ridge Road, Singapore 119228, Singapore
2Department of Paediatrics, Yong Loo Lin School of Medicine, National
University of Singapore, Singapore, Singapore
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Soh et al. World Allergy Organization Journal  (2017) 10:3 
DOI 10.1186/s40413-016-0136-x
carbohydrate rather than a protein. GOS is a small mol-
ecule and thus is unlikely to crosslink IgE on the surface
of mast cells. However, it may be immunogenic when
coupled to carrier proteins, as demonstrated in guinea
pigs [15]. Protein contamination from the manufacturing
process for GOS has been ruled out as the mixtures have
been shown to have undetectable to low protein levels
(50 ng protein per 1 mg of GOS) [16] and our earlier
study [16] also demonstrated the absence of IgE
sensitization (skin prick tests and basophil activation
tests) to the enzyme β galactosidase.
We have previously described GOS allergy in older
children and an adult male [16]. Since then, we have
been performing further surveillance study of GOS al-
lergy seen in the Accident and Emergency Departments
of three local hospitals. Based on this surveillance, new
cases of GOS allergy were identified in pregnant and lac-
tating mothers. Here, we report a series of mothers who
presented with acute GOS allergy after consumption of
GOS-containing milk formula.
Case presentations
From November 2012 to May 2016, six mothers devel-
oped allergic reactions after consuming cow’s milk-based
formulae supplemented with GOSproduced with β ga-
lactosidase from Bacillus circulans.. These women were
either referred to our institution or were seen in the Ac-
cident and Emergency department of the National Uni-
versity Hospital of Singapore, which is one of the tertiary
hospitals in the country. All subjects resided in Singapore
except for one subject who was referred by her allergist
from Kuala Lumpur, Malaysia. These women were
aged 26–40 years old. All were previously ingesting
dairy products without problems. Four had their aller-
gic reactions to GOS containing formula during preg-
nancy, three in the third trimester and one in the
first trimester; the other two had reactions in the
postnatal period.
The suspected allergen was a commercial cow’s milk
formulated for pre- and postnatal mothers. All reactions
occurred at the first ingestion of the suspected milk for-
mula, suggesting a cross-reaction typical of GOS allergy
in our population [16]; the mothers had not taken these
formulae previously. Reactions occurred 15–30 min after
ingestion of the formula (Table 1). The amount ingested
ranged from 100 ml to 250 ml (approximately 0.72 to
1.9gm of GOS). All had nasal symptoms; 4/6 had angio-
edema of the eyes (Table 1). Five of six women had ana-
phylaxis as per WAO criteria [13]. These criteria consist
of any one of the following three:
1. acute-onset illness with involvement of the skin and/
or mucosae, and at least one of respiratory
compromise/reduced blood pressure/symptoms of
end-organ dysfunction; or
2. rapid occurrence after exposure to a likely allergen
for a patient, of at least two of skin-mucosae involve-
ment/respiratory compromise/reduced blood pres-
sure or symptoms thereof/persistent gastrointestinal
symptoms; or
3. reduced blood pressure after exposure to a known
allergen for the patient).





















P1 Prenatal Chronic rhinitis Unknown Unknown 30 Rhinorrhea, Throat tightness









200 1.5 15 Eye swelling, congested nose,
itchy throat, cough, wheezing
No 6
P3 Prenatal Aspirin allergy 250 1.9 30 Eye and lip swelling, congested
nose, itchy throat, hives, red skin
500 μg 6




200–250 1.5–1.9 30 Eye swelling, congested nose,
throat tightness, cough, red skin
No 6
P5 Prenatal Chronic rhinitis 100 0.72 g 40 Angioedema, running nose,
watery eyes, sneezing,itchy
throat, throat tightness, cough,
wheezing, hoarseness of voice
No 5
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Four of the patients promptly visited the Emergency
Department for their symptoms. Of the five women who
had anaphylaxis, two received intramuscular adrenaline.
None of the patients required hospitalization.
All six women were atopic as characterized by sensi-
tisation to house dust mites in Singapore [18], and had
positive skin prick tests to the house dust mites Derma-
tophagoides pteronyssinus, Dermatophagoides farinae,
and Blomia tropicalis. The subjects did not have any
other documented allergies. It is not uncommon that in
our tropical environment atopics are monosensitised to
dust mites only [18]. No other allergy tests other than to
dust mites were performed, as our subjects reported re-
spiratory allergies as their comorbid condition which is
strongly associated with dust mite monosensitization in
Singapore.
Five of six subjects had a history of respiratory allergies
(chronic rhinitis, asthma). All patients had positive skin
prick test to GOS, and all five women who were tested
had positive basophil activation tests to GOS (Figure 1).
The GOS used in this investigation was kindly provided
by Friesland Campina (Amersfoort, Netherlands). The
sixth patient was from Kuala Lumpur, Malaysia, hence the
blood sampling for basophil activation test was not
feasible.
The babies born to the four mothers who had reac-
tions during pregnancy, were of normal birth weight
with no congenital defects or perinatal problems. There
have been no recurrences of the mothers’ allergic reac-
tions after avoiding GOS-containing milks.
Discussion
Anaphylaxis in pregnancy is rare, with one study esti-
mating prevalence near or at the time of delivery as
2.7 cases of anaphylaxis per 100,000 deliveries [2]. In
this report, we describe an unusual cause of anaphyl-
axis in mothers, namely to GOS which was added as
a prebiotic supplement to milk formula. The new for-
mulation of milk formula intended for pregnant and
lactating women in Singapore, has had GOS removed
from its ingredients. Therefore, it is unlikely that
further anaphylactic reactions to GOS will occur in
pregnant/lactating women. Of interest is the geo-
graphic restriction of cases of GOS-related allergy to
South East Asia despite GOS being available world-
wide, suggesting that the primary sensitizer is likewise
specific to this region. It may be caused by an insect
bite, akin to alpha-gal allergy associated with tick
bites in the United States of America [19], Australia
[20], Europe [21] and more recently, Japan [22].
Mosquito bites are frequent in Asia and the species
varies with geographic region. The mechanism of
sensitization remains unknown. Commins et al [23]
summarised the historical and scientific evidence
pointing to tick bites as the cause of development of
alpha-gal allergy. Hapten sensitization, where the indi-
vidual develops sensitization to the oligosaccharide
when bound to a carrier protein, seems a plausible
explanation but requires further investigation.
In pregnant mothers, management of any anaphylaxis is
similar to that in non-pregnant patients in most respects.
Adrenaline, administered promptly via intramuscular in-
jection, is first-line therapy. The additional factor is the
presence of the foetus: the pregnant patient should be
placed semi-recumbent on her left side with the lower ex-
tremities elevated, to prevent positional hypotension
resulting from compression of the inferior vena cava by
the gravid uterus. In addition, monitoring of the fetal heart
rate is recommended in women more than 24 weeks preg-
nant, with persistent fetal distress being an indication to
consider emergency cesarean section [24].
In maternal anaphylaxis, the foetus tends to come off
worst [1, 4, 25–27]. Various reports in the literature de-
scribe neonatal deaths and neurological damage, related
to maternal anaphylaxis after the mothers received anti-
biotics in the hospital [25–27]. Berenguer et al [4] re-
cently reported the demise of a neonate who was born
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Fig. 1 Dose-dependent effect of GOS on activation of basophils. The expression of CD203c (left panel) and CD63 (right panel) on basophils after
stimulating with various concentration of GOS were analyzed by flow cytometry. P1-5 denotes patients 1–5 as described in Table. Basophil activation
assay was performed as described previously [11]. The cells stimulated with anti-IgE Ab (1ug/ml) was used as the positive control (data not shown)
Soh et al. World Allergy Organization Journal  (2017) 10:3 Page 3 of 5
maternal anaphylaxis after receiving amoxycillin in the
community setting.
It is further unclear as to how much of this fetal mor-
bidity and mortality may be related to administration of
adrenaline. Adrenaline is a potent vasoconstrictor. It is
thus possible that adrenaline, especially at high cumula-
tive doses, may cause uterine vasoconstriction with con-
sequent fetal hypoperfusion and the consequences
thereof, including brain damage and death [28, 29].
Thus, it may be prudent to temper the use of adrenaline
if there are no severe or life-threatening features of ana-
phylaxis such as airway compromise or hypotension. In
our series, only two of the mothers received adrenaline
and all mothers and neonates had an excellent outcome.
There were no biphasic reactions; however, our case
series is small. Given that this is a relatively new
phenomenon, the frequency of biphasic reactions is un-
clear. Thus, it may be prudent to admit these mothers
for observation in the hospital ward.
As mentioned, of the five cases of GOS-related ana-
phylaxis described in the current case report, only two
received intramuscular adrenaline. All of the mothers
and their babies had normal neonatal outcomes after the
reactions.
Conclusion
GOS-related allergy has manifested as anaphylaxis due
to milk formula ingestion in a small number of prenatal
and postnatal mothers with pre-existing atopy. Since the
new formulation of milk formula intended for pregnant
and lactating women in Singapore does not contain
GOS, it is unlikely that such GOS-related allergy cases
will occur in the future. The supplementation of GOS
into milk and beverages in the South East Asian region
should take into account the rare chance of allergenicity
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